Brief: Cytodyn’S Phase 2 Basket Trial For 22 Solid Cancer Tumors Treats First Patient With Leronlimab Patient Enrollment Delayed Due To Covid-19
15/04/2020 11:16
April 15 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN’S PHASE 2 BASKET TRIAL FOR 22 SOLID CANCER TUMORS
TREATS
FIRST PATIENT WITH LERONLIMAB; PATIENT ENROLLMENT DELAYED DUE TO
COVID-19
Source text for Eikon: ID:nGNX7jSwkz
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer